Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
4.500
0.00 (0.00%)
May 7, 2026, 3:43 PM HKT
HKG:2563 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 456.77 | 189.71 | 38.09 | 60.11 | 268.42 |
Short-Term Investments | - | 268.74 | 302.32 | 224.17 | - |
Trading Asset Securities | - | 105.99 | 235.61 | 444.99 | 536.96 |
Cash & Short-Term Investments | 456.77 | 564.44 | 576.02 | 729.26 | 805.37 |
Cash Growth | -19.08% | -2.01% | -21.01% | -9.45% | -8.33% |
Accounts Receivable | 7.16 | 23.15 | 11.16 | 34.62 | 25.12 |
Other Receivables | 58.87 | 4.99 | 4.79 | 4.33 | 0.57 |
Receivables | 66.02 | 28.14 | 15.95 | 38.95 | 25.81 |
Inventory | 45.49 | 31.42 | 27.27 | 31.11 | 22.67 |
Restricted Cash | - | 8.18 | - | - | - |
Other Current Assets | 9.75 | 67.08 | 14.3 | 5.35 | 12.45 |
Total Current Assets | 578.03 | 699.26 | 633.53 | 804.67 | 866.3 |
Property, Plant & Equipment | 147.89 | 177.28 | 136.19 | 117.76 | 79.47 |
Other Intangible Assets | 12.45 | 0.75 | 1.63 | 2.83 | 16.31 |
Other Long-Term Assets | 35.9 | 35.95 | 1 | 1.07 | 1.99 |
Total Assets | 774.27 | 913.24 | 772.34 | 926.34 | 964.06 |
Accounts Payable | 53.82 | 48.33 | 24.44 | 20.1 | 4.28 |
Accrued Expenses | 2.88 | 8.38 | 10.75 | 11.89 | 10 |
Current Portion of Long-Term Debt | 1.05 | - | - | - | - |
Current Portion of Leases | - | 0.67 | 0.73 | 1.09 | 0.67 |
Current Income Taxes Payable | 0.16 | - | - | - | 0 |
Current Unearned Revenue | 4.8 | 4.72 | - | - | 1 |
Other Current Liabilities | 6.7 | 17.07 | 7.83 | 18.64 | 2.21 |
Total Current Liabilities | 69.41 | 79.16 | 43.74 | 51.73 | 18.16 |
Long-Term Leases | 0.93 | 0.52 | 0.17 | 0.81 | 0.48 |
Long-Term Unearned Revenue | 0.12 | 42.82 | 0.82 | 1.53 | 1.56 |
Other Long-Term Liabilities | 37.74 | - | 4.45 | 4.35 | - |
Total Liabilities | 108.19 | 122.5 | 49.18 | 58.41 | 20.2 |
Common Stock | 364.59 | 364.59 | 350 | 350 | 350 |
Additional Paid-In Capital | - | - | - | - | 972.05 |
Retained Earnings | -1,004 | - | - | - | -378.19 |
Comprehensive Income & Other | 1,305 | 426.16 | 373.16 | 517.93 | - |
Shareholders' Equity | 666.08 | 790.75 | 723.16 | 867.93 | 943.87 |
Total Liabilities & Equity | 774.27 | 913.24 | 772.34 | 926.34 | 964.06 |
Total Debt | 1.97 | 1.18 | 0.9 | 1.9 | 1.14 |
Net Cash (Debt) | 454.79 | 563.26 | 575.12 | 727.36 | 804.23 |
Net Cash Growth | -19.26% | -2.06% | -20.93% | -9.56% | -8.46% |
Net Cash Per Share | 1.25 | 1.60 | 1.64 | 2.08 | 2.30 |
Filing Date Shares Outstanding | 365.61 | 364.59 | 350 | 350 | 350 |
Total Common Shares Outstanding | 365.61 | 364.59 | 350 | 350 | 350 |
Working Capital | 508.62 | 620.1 | 589.79 | 752.95 | 848.14 |
Book Value Per Share | 1.82 | 2.17 | 2.07 | 2.48 | 2.70 |
Tangible Book Value | 653.63 | 789.99 | 721.53 | 865.09 | 927.56 |
Tangible Book Value Per Share | 1.79 | 2.17 | 2.06 | 2.47 | 2.65 |
Buildings | - | 75.42 | 72.76 | 72.69 | 67.93 |
Machinery | - | 42.36 | 42.86 | 41.47 | 38.55 |
Construction In Progress | - | 97.66 | 53.37 | 26.99 | 2.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.